Promises and challenges of personalized medicine to guide ARDS therapy
Abstract Identifying new effective treatments for the acute respiratory distress syndrome (ARDS), including COVID-19 ARDS, remains a challenge. The field of ARDS investigation is moving increasingly toward innovative approaches such as the personalization of therapy to biological and clinical sub-ph...
Main Authors: | Katherine D. Wick, Daniel F. McAuley, Joseph E. Levitt, Jeremy R. Beitler, Djillali Annane, Elisabeth D. Riviello, Carolyn S. Calfee, Michael A. Matthay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-021-03822-z |
Similar Items
-
Corticosteroids in ARDS
by: Emmanuelle Kuperminc, et al.
Published: (2023-05-01) -
Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
by: Andrea R. Levine, et al.
Published: (2024-01-01) -
Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials
by: Shaun M. Pienkos, et al.
Published: (2023-03-01) -
Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies
by: Rejina Mariam Verghis, et al.
Published: (2023-03-01) -
Clinical Utility of the Sivelestat for the Treatment of ALI/ARDS: Moving on in the Controversy?
by: Qiongli Ding, et al.
Published: (2022-08-01)